Amgen Profit Beats Estimates as Drugmaker Raises Forecast

April 21, 2015 9:01 PM

70 0

Amgen Inc., the maker of cancer treatments and blood boosters to combat anemia, reported first-quarter profit that topped analysts’ estimates and raised its forecast for the year on stronger-than-expected drug sales. The shares rose in late trading.

Earnings excluding one-time items rose to $2.48 a share from $1.87 a year earlier. Analysts had forecast $2.10 on average, according to estimates compiled by Bloomberg. Revenue increased 11 percent to $5.03 billion, the Thousand Oaks, California-based company said Tuesday in a statement. Analysts ha...

Also read: Asian stocks fall in muted trading amid trade uncertainty

Read more

To category page